LifeStance Health Group, Inc. vs Privia Health Group, Inc., two Medical Services stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where LFST and PRVA diverge most: on debt / equity, LFST reads 0.19 and PRVA reads 0.00; on operating margin, LFST reads 7.0% and PRVA reads 1.9%. The rest of the comparable metrics sit closer together. What PRVA's price implies is a somewhat stretched bet versus history (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | LFST | PRVA |
|---|---|---|
| Price | $12.43 | $20.85 |
| Market cap | $4.8B | $2.7B |
| Sector | Medical Services | Medical Services |
| Stage | Growth | Growth |
| P/E | — | 94.8 |
| P/B | 3.26 | 3.28 |
| P/S | 3.04 | 1.17 |
| EV/EBITDA | 36.6 | 41.0 |
| Revenue growth | +20.3% | +24.3% |
| Operating margin | 7.0% | 1.9% |
| Net margin | 3.2% | 1.2% |
| Return on equity | 3.4% | 3.4% |
| Return on assets | 2.3% | 1.9% |
| Return on invested capital | 3.9% | 3.1% |
| FCF yield | 3.6% | 4.8% |
| Debt / equity | 0.19 | 0.00 |
| Current ratio | 1.38 | 1.62 |
| Altman Z (solvency) | 4.44 | 4.32 |
| Piotroski F (quality) | 8 / 9 | 5 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.